• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ramitens
    / Rafa


    Active Ingredient
    Ramipril 10 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Capsules

    30 X 10 mg

    partial basket chart 65592 18343

    Dosage

    See prescribing information for full details.


    Indications

    Hypertension, congestive heart failure, reduction of mortality after myocardial infarction (M.I.) with left ventricular dysfunction. For reducing the risk of M.I., stroke, cardiovascular death or need for revascularization procedures in patients 55 years or more who have clinical evidence of cardiovascular disease (previous M.I., unstable angina, or multivessel CABG or multivessel PTCA), stroke or peripheral vascular disease. Also for reducing the risk of M.I., stroke, cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings: Hypertension (systolic pressure >160 mmHg or diastolic pressure >90 mmHg); high total cholesterol (>5.2 mmol/L); low HDL (<0.9 mmol/L).


    Contra-Indications

    See prescribing information for full details.


    Manufacturer
    Rafa Laboratories Ltd.
    CLOSE